Cardiff University Brain Research Imaging Centre (CUBRIC), Cardiff University, Cardiff, UK.
School of Computer Science and Informatics, Cardiff University, Cardiff, UK.
NMR Biomed. 2024 Dec;37(12):e5229. doi: 10.1002/nbm.5229. Epub 2024 Aug 27.
Diffusion-weighted MRI (dMRI) is universally recommended for the detection and classification of prostate cancer (PCa), with PI-RADS recommendations to acquire b-values of ≥1.4 ms/μm. However, clinical dMRI suffers from a low signal-to-noise ratio (SNR) as the consequence of prolonged echo times (TEs) attributable to the limited gradient power in the range of 40-80 mT/m. To overcome this, MRI systems with strong gradients have been designed but so far have mainly been applied in the brain. The aim of this work was to assess the feasibility, data quality, SNR and contrast-to-noise ratio (CNR) of measurements in PCa with a 300 mT/m whole-body system. A cohort of men without and with diagnosed PCa were imaged on a research-only 3T Connectom Siemens MRI system equipped with a gradient amplitude of 300 mT/m. dMRI at high b-values were acquired using high gradient amplitudes and compared with gradient capabilities mimicking clinical systems. Data artefacts typically amplified with stronger gradients were assessed and their correction evaluated. The SNR gains and lesion-to-healthy tissue CNR were statistically tested investigating the effect of protocol and b-value. The diagnostic quality of the images for different dMRI protocols was assessed by an experienced radiologist using a 5-point Likert scale and an adapted PI-QUAL scoring system. The strong gradients for prostate dMRI allowed a significant gain in SNR per unit time compared with clinical gradients. Furthermore, a 1.6-2.1-fold increase in CNR was observed. Despite the more pronounced artefacts typically associated with strong gradients, a satisfactory correction could be achieved. Smoother and less biased parameter maps were obtained with protocols at shorter TEs. The results of this study show that dMRI in PCa with a whole-body 300-mT/m scanner is feasible without a report of physiological effects, SNR and CNR can be improved compared with lower gradient strengths, and artefacts do not negate the benefits of strong gradients and can be ameliorated. This assessment provides the first essential step towards unveiling the full potential of cutting-edge scanners, now increasingly becoming available, to advance early detection and diagnostic precision.
扩散加权磁共振成像(dMRI)普遍被推荐用于前列腺癌(PCa)的检测和分类,PI-RADS 建议采集 b 值≥1.4 ms/μm。然而,临床 dMRI 由于受限于 40-80 mT/m 范围内的梯度功率,其信号噪声比(SNR)较低,导致回波时间(TE)延长。为了克服这一问题,设计了具有强梯度的 MRI 系统,但迄今为止,这些系统主要应用于大脑。本研究旨在评估配备 300 mT/m 全身系统的强梯度在 PCa 中的可行性、数据质量、SNR 和对比噪声比(CNR)。一组无前列腺癌和诊断为前列腺癌的男性患者在配备 300 mT/m 梯度强度的研究型西门子 3T Connectom MRI 系统上进行成像。采用高梯度强度采集高 b 值 dMRI,并与模拟临床系统的梯度能力进行比较。评估了通常随强梯度放大的数据伪影,并对其校正效果进行了评价。通过研究协议和 b 值的影响,对 SNR 增益和病变与健康组织的 CNR 进行了统计学检验。不同 dMRI 协议的图像诊断质量由一名经验丰富的放射科医生使用 5 分李克特量表和改良的 PI-QUAL 评分系统进行评估。与临床梯度相比,前列腺 dMRI 的强梯度允许在单位时间内 SNR 显著提高。此外,还观察到 CNR 增加了 1.6-2.1 倍。尽管通常与强梯度相关的伪影更为明显,但仍可实现令人满意的校正。采用较短 TE 的协议可以获得更平滑、偏差更小的参数图。本研究结果表明,配备全身 300 mT/m 扫描仪的前列腺癌 dMRI 是可行的,且没有报告生理效应,与较低梯度强度相比,SNR 和 CNR 可以提高,伪影不会否定强梯度的优势,并且可以得到改善。该评估为揭示日益普及的前沿扫描仪的全部潜力提供了第一个重要步骤,这些扫描仪可以提高早期检测和诊断精度。